Philip C. Craven
- Infectious Diseases top 2%
- Epidemiology top 5%
- Molecular Biology
- Pharmacology top 10%
- Small Animals top 5%
- Co-authors
- John R. GraybillDavid WilliamsWayne E. MageeDavid J. DrutzRobert L. TaylorWilliam E. DismukesGretchen A. CloudDavid H. Gremillion
- Topics
- Antifungal resistance and susceptibility (12 papers)Fungal Infections and Studies (12 papers)Nail Diseases and Treatments (3 papers)
- Journals
- New England Journal of MedicineAnnals of Internal MedicineAnnals of the New York Academy of Sciences
- Partner nations
- United States
In The Last Decade
Philip C. Craven
24 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Infectious Diseases 779
- Epidemiology 688
- Molecular Biology 178
- Pharmacology 140
- Small Animals 116
Countries citing papers authored by Philip C. Craven
This map shows the geographic impact of Philip C. Craven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Craven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Craven more than expected).
Fields of papers citing papers by Philip C. Craven
This network shows the impact of papers produced by Philip C. Craven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Craven. The network helps show where Philip C. Craven may publish in the future.
Co-authorship network of co-authors of Philip C. Craven
This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Craven. A scholar is included among the top collaborators of Philip C. Craven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Craven. Philip C. Craven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Ketoconazole Therapy for Systemic Fungal Infections | 0 |
| 2 | Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issues. | 16 |
| 3 | 79 | |
| 4 | 4 | |
| 5 | 17 | |
| 6 | 101 | |
| 7 | 296 | |
| 8 | 49 | |
| 9 | 24 | |
| 10 | 18 | |
| 11 | 63 | |
| 12 | 90 | |
| 13 | 76 | |
| 14 | 127 | |
| 15 | 11 | |
| 16 | 163 | |
| 17 | 1 | |
| 18 | An Epidemic on Two Pediatric Wards | 3 |
| 19 | 9 | |
| 20 | 33 |
About Philip C. Craven
Philip C. Craven is a scholar working on Microbiology, Infectious Diseases and Microbiology, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (12 papers) and Nail Diseases and Treatments (3 papers). The work is most often cited by research in Microbiology (45 citations), Infectious Diseases (779 citations) and Epidemiology (688 citations). Philip C. Craven has collaborated with scholars based in United States. Frequent co-authors include John R. Graybill, David Williams, Wayne E. Magee, David J. Drutz, Robert L. Taylor, William E. Dismukes, Gretchen A. Cloud, David H. Gremillion, Alan D. Tice and Clark R. Gregg. Their work appears in journals such as New England Journal of Medicine, Annals of Internal Medicine and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.